Philips announces collaboration with medtronic to further advance the what is ledderhose disease image-guided treatment of atrial fibrillation pressreleasepoint

Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance treatment what is ledderhose disease of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips what is ledderhose disease to provide an innovative, integrated image guidance solution for cryoablation procedures. Philips will bring to market the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features what is ledderhose disease to enable electrophysiologists to perform cryoablation procedures with reduced need what is ledderhose disease for X-ray imaging.

Atrial fibrillation (AF) affects more than 33 million people worldwide [1]. Cryoballoon ablation is used in a minimally invasive procedure to what is ledderhose disease isolate the pulmonary veins, which are a source of erratic electrical signals that cause what is ledderhose disease AF. The technology uses cold energy rather than heat (radio frequency (RF) ablation) to create scar tissue and interrupt these irregular electrical pathways what is ledderhose disease in the heart.

“ This integrated solution can guide physicians during the treatment of what is ledderhose disease AF patients with ablation, as they can view detailed, CT-like 3D anatomy, reducing the need for X-ray imaging,” said Marlou Janssen, Business Leader Philips EPD Solutions. “Partnering with Medtronic extends the reach of our KODEX-EPD cardiac imaging and navigation system. Today, this technology is simplifying navigation, and in the future it has potential for a wide what is ledderhose disease range of applications, including addressing the key unmet need of real-time therapy assessment – one of the more significant limitations of the current standard what is ledderhose disease of care.”

" When available, physicians will have the ability to use an innovative cardiac what is ledderhose disease imaging and mapping system during cryoablation procedures, while also realizing the significant benefits of our best-in-class cryoablation therapy," said Rebecca Seidel, vice president and general manager of the Atrial Fibrillation Solutions what is ledderhose disease division, which is part of the Cardiac and Vascular Group at what is ledderhose disease Medtronic. “AF is a growing epidemic and we are committed to what is ledderhose disease providing solutions to electrophysiologists that help address the needs of what is ledderhose disease their patients."

Philips’ KODEX-EPD system uses dielectric imaging to create CT-like 3D, high-definition images of a patient’s cardiac structures in real time [2]. A completely new approach to imaging the heart, dielectric imaging offers many benefits in comparison to current approaches, for both cryo and RF ablation procedures. The technology provides real-time 3D imaging, reducing the need for X-ray imaging. It also has mapping capabilities without the need to reset what is ledderhose disease a reference point if the patient moves. As a result, the KODEX-EPD system provides excellent visualization and simplifies navigation, enhancing procedure efficiency and patient care.

KODEX-EPD is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for mapping and navigation during arrhythmia ablation procedures. KODEX-EPD systems are in clinical use at limited sites worldwide. The integrated solution to support cryoablation procedures is intended to what is ledderhose disease be available for sale in the U.S. and Europe in Q4 2019.